Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
02-2019 | 11-2018 | 08-2018 | 05-2018 | 02-2018 | |
Operating Expenses | 758 | 557 | 0 | 578 | 799 |
Operating Income | -758 | -557 | N/A | -578 | -799 |
Other Income | 333 | 0 | 0 | 0 | 0 |
Pre-tax Income | -425 | -557 | 0 | -578 | -799 |
Net Income Continuous | -425 | -557 | N/A | -578 | -799 |
Net Income | $-425 | $-557 | $N/A | $-578 | $-799 |
EPS Basic Total Ops | -3.30 | -4.80 | N/A | -5.40 | -1.05 |
EPS Basic Continuous Ops | -3.32 | -4.76 | N/A | -5.44 | -1.03 |
EPS Diluted Total Ops | -6.00 | -4.80 | N/A | -5.40 | -1.05 |
EPS Diluted Continuous Ops | -3.32 | -4.76 | N/A | -5.44 | -1.03 |
EBITDA(a) | $-758 | $-557 | $N/A | $-578 | $-798 |